Mechanistically, MARCO+ macrophages enhance the proliferative activity of Tregs and IL-10 production as well as reduce CD8+ T cell activity, creating a suppressive microenvironment suitable for tumor cell survival [96, 97]. The gene discussed is IL10; the disease is neoplasm.